John Joly, PhD

CMC Advisor

John is a CMC consultant and has been for the past four years. Prior to the that John worked for 26 years in Pharma Technical Development at Genentech. He led Early Stage Cell Culture including cell line development for 10 years and led Analytical Development & Clinical QC for 4 years. He was also the CMC sub team leader for Lucentis during late stage clinical development up to the BLA filing. During his tenure leading Early Stage Cell Culture his team moved dozens of large molecule research candidates into clinical development. During his time leading Analytical Development & Clinical QC his team filed three BLAs for new molecular entities.